Category Archives: Research

11Jul/21

Genetic factors linked to response to common antiviral medications

St. Jude Children’s Research Hospital scientists and collaborators in Sweden and Japan are reporting that the enzyme NUDT15 plays a role in how patients respond to antiviral therapy with the common drugs ganciclovir and acyclovir. The researchers showed that NUDT15 status can help predict how individuals will respond to treatment for cytomegalovirus, a serious infection common among people who receive bone marrow transplants. The paper was published today in Nature Communications. Continue reading

28May/21

Latest global data finds nearly 8 million deaths from smoking in 2019, and 90% of new smokers addicted by age 25

The most comprehensive data on global trends in smoking highlight its enormous global health toll. The number of smokers worldwide has increased to 1.1 billion in 2019, with tobacco smoking causing 7.7 million deaths – including 1 in 5 deaths in males worldwide. Continue reading

27May/21

As India Burns Amid a Lethal 2nd Wave, It’s Now Evident that the World Has Failed in Ensuring Equitable Access to Vaccines. While Vaccine Doses Reach 9.7 Billion by 2025, Will They be Equitably Distributed?

A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released the 1st edition of its report titled “COVID-19 Vaccines – Global Market Trajectory & Analytics”. The report presents fresh perspectives on what to expect post commercialization of COVID-19 vaccines amid the rising spirit of vaccine nationalism, selfish international politics over vaccines, inadequate market access, stockpiling, and vaccine patents that still remain firmly in place. Continue reading

10May/21

deCODE genetics – Rounding off the human genome

In a study published today, scientists at deCODE Genetics demonstrate for the first time how long-read DNA sequencing can be applied at population scale to unravel large structural variants that associate with human disease and other traits. Continue reading

09Feb/21

Azerbaijan issues permit to conduct world’s first clinical trials of vaccine combination – Sputnik V and the AstraZeneca COVID-19 vaccine

Clinical trials of the combination of Sputnik V and AstraZeneca vaccines will begin in February 2021

The studies will assess the immunogenicity and safety of combined vaccine usage

The joint research is important in developing an approach to combat future mutations Continue reading

19Oct/20

MED-EL: First Surgeries Ever in Europe with a Totally Implantable Cochlear Implant

Leading hearing implant manufacturer MED-EL sets another revolutionary milestone in its long-standing history of technological innovations. On 24 September, the first person in Europe received a novel totally implantable cochlear implant (TICI). It was implanted by Prof. Dr. Philippe Lefebvre, head of the ENT Department of the CHU of Liège and Professor at the University of Liège in Belgium within a feasibility study. The TICI is expected to give users great hearing with even more comfort. However, it will take several years before it receives market approval. Read more

21Sep/20

Axon Neuroscience to launch world’s first crowdfunded vaccine against COVID-19

AXON Neuroscience (“Axon”), a clinical-stage biotech company and an industry leader in treating and preventing neurodegenerative diseases with a unique peptide vaccine platform, is launching the world’s first independently-developed crowdfunded vaccine against COVID-19 – ACvac1. Read more

27Jul/20

University of Cambridge researchers and Huma begin in-depth study of early detection of COVID-19 infection

UK digital health and therapeutics company Huma is teaming up with the renowned Fenland Study research team at the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge to begin a study to understand the progression and early signs of COVID-19 infection. Read more

23May/20

SAS launches free AI-driven environment to mine COVID-19 research

Globally, thousands of scientists are working tirelessly on COVID-19 mitigation efforts, including the search for new treatments and a vaccine. Analytics leader SAS brings a powerful resource to the fight with COVID-19 Scientific Literature Search and Text Analysis, a free visual text analysis environment that uses artificial intelligence (AI) and machine learning to quickly search tens of thousands of research articles on COVID-19 and deliver potentially lifesaving answers to these scientists. Read more